Clin2
NCT06911424Possibly a fitRecruiting

Fusidic acid eye drops for bacterial pink eye

Bacterial Conjunctivitis

Part of Eyes & vision, Infections clinical trials.

This trial tests an antibiotic eye drop called fusidic acid for bacterial conjunctivitis (pink eye). It may help clear the infection if you have had symptoms for less than 48 hours and have not used other eye treatments recently.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
400 people
Ages
Any age
Study type
Interventional

Who can take part

  • You have bacterial pink eye in at least one eye, with yellow/green discharge and a red eye.
  • You have not used any eye drops or ointments for pink eye in the last 14 days.
  • You have tested negative for viral pink eye in both eyes.
  • You agree not to wear contact lenses or use eye makeup during the study.
  • You are not pregnant, breastfeeding, or at risk of pregnancy without using birth control.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07565103Recruiting· Phase 1/Phase 2
Testing SUM-191 eye drops for bacterial pink eye

This trial tests a new eye medication called SUM-191 for treating bacterial conjunctivitis (a bacterial infection that causes pink eye). The study has three parts: first testing safety in healthy people, then in people with the infection itself.

Austin, Texas
NCT06451172Recruiting· Early Phase 1
New antibiotic eye drops for drug-resistant eye infections

This trial tests a new type of antibiotic eye drop for people with serious eye infections that don't respond to standard antibiotics. It aims to see if these drops can safely treat the infection and help improve vision.

Shanghai, Shanghai Municipality
NCT04258787Recruiting
Eye drop treatment for Fuchs corneal swelling

This trial studies a treatment for people with Fuchs’ dystrophy that affects the clear layer at the back of the cornea. It may help improve how clear your vision is after the cornea can no longer pump fluid out properly.

Portland, Oregon
NCT07743489Not yet recruiting· Phase 3
Light therapy for fungal eye infection

This study tests a new light-based treatment for a fungal eye infection called Fusarium keratitis. It aims to see if this therapy can help improve vision and clear the infection.

Palo Alto, California
NCT06969586Enrolling by invitation
Eye drops study for Fuchs corneal disease and glaucoma

This study tests whether special eye drops (Rho-kinase inhibitors) can improve the health of the cornea in people who have both Fuchs endothelial corneal dystrophy and glaucoma. The drops may help reduce corneal swelling and preserve your vision.

Zagreb, Croatia
NCT07308938Not yet recruiting· Phase 2
Steroid eye drops as add-on therapy for bacterial corneal ulcers

This study is testing a steroid eye drop (fluorometholone) as an add-on to standard antibiotic treatment for bacterial corneal ulcers. The goal is to see if adding the steroid helps reduce inflammation and improves healing compared to antibiotics alone.

Pittsburgh, Pennsylvania

Hear when a new Bacterial Conjunctivitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.